Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Citations 0
This Week in JAMA
April 6, 2005

This Week in JAMA

JAMA. 2005;293(13):1549. doi:10.1001/jama.293.13.1549
CVD Outcomes in Black Patients With Hypertension

To assess whether treatment with angiotensin-converting enzyme (ACE) inhibitors or calcium channel blockers (CCBs) is superior to a thiazide-type diuretic to reduce the incidence of cardiovascular disease (CVD) in blacks vs nonblacks with hypertension, Wright and colleaguesArticle analyzed data from the ALLHAT study, in which participants were randomly assigned to a CCB (amlodipine), an ACE inhibitor (lisinopril), or a thiazide-type diuretic (chlorthalidone) and followed up for a mean of 4.9 years. In both black and nonblack participants, the authors found no significant differences by treatment for the primary outcome of combined fatal coronary heart disease and nonfatal myocardial infarction or for any other major CVD or renal outcome. In an editorial,Article Neaton and Kuller discuss previous hypertension treatment trials and possible explanations for race-specific outcomes in ALLHAT.

Predictors of Mortality and Cardiovascular Events

Natriuretic peptide levels predict outcome for patients with established heart disease, but no studies have assessed their prognostic value in healthy individuals or in comparison with other biomarkers of cardiac risk. Kistorp and colleaguesArticle assessed the risk of mortality and first major cardiovascular event by baseline levels of N-terminal prohormone brain natriuretic peptide (NT-proBNP), C-reactive protein (CRP), and urinary albumin/creatinine ratio in a cohort of older adults with no history of cardiovascular disease. They found significant associations between increased baseline levels of NT-proBNP and mortality and first cardiovascular event. These associations were stronger than those for CRP and mortality or first cardiovascular event and were independent of traditional risk factors. In an editorial,Article Schillinger discusses the mechanisms of disease associated with NT-proBNP, CRP, and urinary albumin/creatinine ratio, and their clinical utility.

Injectable Naltrexone for Alcohol Dependence

Oral naltrexone is an effective treatment for alcohol dependence, but adherence to daily therapy can be poor. Garbutt and colleagues assessed the efficacy and tolerability of a long-acting intramuscular formulation of naltrexone, at a dose of 380 mg or 190 mg administered monthly, compared with a placebo injection and combined with a low-intensity psychosocial intervention in adult alcohol-dependent patients. They found that patients receiving 380 mg of naltrexone had significantly fewer heavy drinking days compared with patients receiving placebo. Naltrexone injections appeared to be well tolerated and adverse events were comparable across the 3 treatment groups.

See Article

Exercise, Stress Management, and Cardiovascular Risk

Psychosocial factors are associated with an increased risk of ischemic heart disease (IHD), but whether modifying these factors will reduce cardiovascular risk is not clear. In a randomized trial, Blumenthal and colleagues studied the effect of adding either exercise training or stress management training to routine medical care vs routine medical care alone on psychosocial functioning and cardiovascular risk in a cohort of patients with stable IHD. They found that patients in both active treatment groups had greater improvements from baseline in psychosocial functioning and intermediate markers of cardiovascular risk compared with patients receiving only routine medical care.

See Article

Medical News & Perspectives

An advisory panel to the US Food and Drug Administration recently recommended that the agency allow continued marketing of cyclooxygenase 2 inhibitors but urged physicians to use greater caution when prescribing all nonsteroidal anti-inflammatory drugs.

See Article

Evaluating Youth Suicide Screening

In a randomized trial, youth asked about suicidal ideation or behavior did not have more distress or increased suicidal ideation after screening compared with youth not asked these questions.

See Article

Compensation Status and Surgical Outcomes

In a meta-analysis of 129 surgical studies, which included data on patients’ workers’ compensation status, patients who received compensation had worse surgical outcomes.

See Article


Clinical Review
A review of clinical symptoms associated with the presence of cell-free hemoglobin suggests that hemolysis and hemoglobinemia should be considered a novel mechanism of disease.

See Article

JAMA Patient Page

For your patients: Information about alcohol abuse and alcoholism.

See Article